Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
Windi Fresha Qomara,1 Delya Nur Primanissa,1 Salma Hasni Amalia,1 Febby V Purwadi,1 Neily Zakiyah1,2 1Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, 40132, Indonesia; 2Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmac...
Guardado en:
Autores principales: | Qomara WF, Primanissa DN, Amalia SH, Purwadi FV, Zakiyah N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fe76092db28e44ccba9d6ff8da472917 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Favipiravir Inhibits Mayaro Virus Infection in Mice
por: Michèle Bengue, et al.
Publicado: (2021) -
Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy
por: Linhu Ye, et al.
Publicado: (2021) -
A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
por: A. Abayomi, et al.
Publicado: (2021) -
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)
por: Stephen I. Walimbwa, et al.
Publicado: (2021) -
Interacciones farmacológicas en niños con infección por VIH en tratamiento con antirretrovirales
por: Castro-Moraga,María Eugenia, et al.
Publicado: (2021)